Statement of Principles concerning giant cell arteritis (Reasonable Hypothesis) (No. 11 of 2021)

Administered by Department of Veterans' Affairs

Legislation au F2021L00008 In force Legislative Instrument

Legislation content

Statement of Principles concerning giant cell arteritis (Reasonable Hypothesis) (No. 11 of 2021)

made under subsection 196B(2) of the

Veterans' Entitlements Act 1986

Compilation No. 1  

Compilation date:   19 September 2022

Includes amendments up to: Veterans' Entitlements (Statements of Principles—definition of "one pack-year") Amendment Determination 2022 (No. 94 of 2022) (F2022L01128)

The day of commencement of this Amendment Determination is 19 September 2022.

 

About this compilation

 

This compilation

This is a compilation of the Statement of Principles concerning giant cell arteritis (Reasonable Hypothesis) (No. 11 of 2021) that shows the text of the law as amended and in force on 19 September 2022.

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.

Uncommenced amendments

The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Legislation Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the series page on the Legislation Register for the compiled law.

Application, saving and transitional provisions for provisions and amendments

If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.

Modifications

If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the series page on the Legislation Register for the compiled law.

Selfrepealing provisions

If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.

 

 

 

 

 

Contents

1 Name

3 Authority

5 Application

6 Definitions

7 Kind of injury, disease or death to which this Statement of Principles relates

8 Basis for determining the factors

9 Factors that must exist

10 Relationship to service............................................

11 Factors referring to an injury or disease covered by another Statement of Principles

Schedule 1 - Dictionary

1 Definitions

Endnotes

Endnote 1—About the endnotes

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history

 


1               Name

This is the Statement of Principles concerning giant cell arteritis (Reasonable Hypothesis) (No. 11 of 2021).

3               Authority

This instrument is made under subsection 196B(2) of the Veterans' Entitlements Act 1986.

5               Application

This instrument applies to a claim to which section 120A of the VEA or section 338 of the Military Rehabilitation and Compensation Act 2004 applies.

6               Definitions

The terms defined in the Schedule 1 - Dictionary have the meaning given when used in this instrument.

7               Kind of injury, disease or death to which this Statement of Principles relates

(1)          This Statement of Principles is about giant cell arteritis and death from giant cell arteritis.

Meaning of giant cell arteritis

(2)          For the purposes of this Statement of Principles, giant cell arteritis means a systemic autoimmune vasculitis that involves large and medium-sized arteries and principally affects the cranial branches of the carotid arteries.

Note 1: Examples of affected arteries include the temporal, occipital, ophthalmic, vertebral, distal subclavian and axillary arteries, and the thoracic aorta. Typical clinical symptoms associated with the involvement of the cranial arteries include headache, visual loss and jaw claudication.

Note 2: This condition is also known as temporal arteritis and cranial arteritis.

(3)          While giant cell arteritis attracts ICD10AM code M31.5 or M31.6, in applying this Statement of Principles the meaning of giant cell arteritis is that given in subsection (2).

(4)          For subsection (3), a reference to an ICD-10-AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM), Tenth Edition, effective date of 1 July 2017, copyrighted by the Independent Hospital Pricing Authority, ISBN 978-1-76007-296-4.

Death from giant cell arteritis

(5)          For the purposes of this Statement of Principles, giant cell arteritis, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's giant cell arteritis.

Note: terminal event is defined in the Schedule 1 - Dictionary.

8               Basis for determining the factors

The Repatriation Medical Authority is of the view that there is sound medicalscientific evidence that indicates that giant cell arteritis and death from giant cell arteritis can be related to relevant service rendered by veterans, members of Peacekeeping Forces, or members of the Forces under the VEA, or members under the MRCA.

Note: MRCA, relevant service and VEA are defined in the Schedule 1 - Dictionary.

9               Factors that must exist

At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting giant cell arteritis or death from giant cell arteritis with the circumstances of a person's relevant service:

(1)          having smoked at least 10 pack-years of tobacco products before the clinical onset of giant cell arteritis, and where smoking has ceased, the clinical onset of giant cell arteritis has occurred within 20 years of cessation;

Note: one pack-year is defined in the Schedule 1 - Dictionary.

(2)          having smoked at least 10 pack-years of tobacco products before the clinical worsening of giant cell arteritis, and where smoking has ceased, the clinical worsening of giant cell arteritis has occurred within 20 years of cessation;

Note: one pack-year is defined in the Schedule 1 - Dictionary.

(3)          inability to obtain appropriate clinical management for giant cell arteritis.

10           Relationship to service

(1)          The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person.

(2)          The factors set out in subsections 9(2) to 9(3) apply only to material contribution to, or aggravation of, giant cell arteritis where the person's giant cell arteritis was suffered or contracted before or during (but did not arise out of) the person's relevant service.

11           Factors referring to an injury or disease covered by another Statement of Principles

In this Statement of Principles:

(1)          if a factor referred to in section 9 applies in relation to a person; and

(2)          that factor refers to an injury or disease in respect of which a Statement of Principles has been determined under subsection 196B(2) of the VEA;

then the factors in that Statement of Principles apply in accordance with the terms of that Statement of Principles as in force from time to time.

 

 

Schedule 1 - Dictionary  

Note: See Section 6

1               Definitions

In this instrument:

                               giant cell arteritis—see subsection 7(2).

                               MRCA means the Military Rehabilitation and Compensation Act 2004.

                               one pack-year means the amount of tobacco consumed in smoking 20 cigarettes per day for a period of 1 year, or an equivalent amount of tobacco products.

Note 1: An equivalent amount of tobacco products is 7,300 grams of smoking tobacco by weight, either in cigarettes, pipe tobacco or cigars, or a combination of same. For pipe tobacco, cigars or combinations of multiple tobacco types, 1 gram of tobacco is considered to be equal to one cigarette.

Note 2: Pack-years are calculated by dividing the number of cigarettes smoked per day by 20 and multiplying this number by the number of years the person has smoked. For example, smoking 10 cigarettes per day for 10 years is equal to 5 pack-years, and smoking 40 cigarettes per day for 10 years is equal to 20 pack-years.

                               relevant service means:

(a)          operational service under the VEA;

(b)          peacekeeping service under the VEA;

(c)          hazardous service under the VEA;

(d)          British nuclear test defence service under the VEA;

(e)          warlike service under the MRCA; or

(f)           non-warlike service under the MRCA.

Note: MRCA and VEA are also defined in the Schedule 1 - Dictionary.

                               terminal event means the proximate or ultimate cause of death and includes the following:

(a)           pneumonia;

(b)           respiratory failure;

(c)           cardiac arrest;

(d)           circulatory failure; or

(e)           cessation of brain function.

                               VEA means the Veterans' Entitlements Act 1986.

 

 

Endnotes

Endnote 1—About the endnotes

The endnotes provide information about this compilation and the compiled law.

The following endnotes are included in every compilation:

Endnote 1—About the endnotes

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history

Abbreviation key—Endnote 2

The abbreviation key sets out abbreviations that may be used in the endnotes.

Legislation history and amendment history—Endnotes 3 and 4

Amending laws are annotated in the legislation history and amendment history.

The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.

The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.

Misdescribed amendments

A misdescribed amendment is an amendment that does not accurately describe the amendment to be made. If, despite the misdescription, the amendment can be given effect as intended, the amendment is incorporated into the compiled law and the abbreviation “(md)” added to the details of the amendment included in the amendment history.

If a misdescribed amendment cannot be given effect as intended, the abbreviation “(md not incorp)” is added to the details of the amendment included in the amendment history. 

Endnote 2—Abbreviation key

 

o = order(s)

ad = added or inserted

Ord = Ordinance

am = amended

orig = original

amdt = amendment

par = paragraph(s)/subparagraph(s)

c = clause(s)

    /subsubparagraph(s)

C[x] = Compilation No. x

pres = present

Ch = Chapter(s)

prev = previous

def = definition(s)

(prev…) = previously

Dict = Dictionary

Pt = Part(s)

disallowed = disallowed by Parliament

r = regulation(s)/rule(s)

Div = Division(s)

 

exp = expires/expired or ceases/ceased to have

reloc = relocated

    effect

renum = renumbered

F = Federal Register of Legislation

rep = repealed

gaz = gazette

rs = repealed and substituted

LA = Legislation Act 2003

s = section(s)/subsection(s)

LIA = Legislative Instruments Act 2003

Sch = Schedule(s)

(md) = misdescribed amendment can be given

Sdiv = Subdivision(s)

    effect

SLI = Select Legislative Instrument

(md not incorp) = misdescribed amendment

SR = Statutory Rules

    cannot be given effect

SubCh = SubChapter(s)

mod = modified/modification

SubPt = Subpart(s)

No. = Number(s)

underlining = whole or part not

 

    commenced or to be commenced

 

Endnote 3—Legislation history

 

Name

Registration

Commencement

Application, saving and transitional provisions

Statement of Principles concerning giant cell arteritis (Reasonable Hypothesis) (No. 11 of 2021)

 

4 January 2021

 

F2021L00008

25 January 2021

 

 

Veterans' Entitlements (Statements of Principles—definition of "one pack-year") Amendment Determination 2022 (No. 94 of 2022)

 

26 August 2022

 

F2022L01128

19 September 2022

 

 

Endnote 4—Amendment history

 

Provision affected

How affected

Section 2……………….

rep LA s 48D

Section 4……………….

rep LA s 48C

Subsection 9(1) note….

rs No. 94 of 2022

Subsection 9(2) note....

rs No. 94 of 2022

Schedule 1 – Dictionary – one pack-year...……..

rs No. 94 of 2022

 

 

Overview

The Statement of Principles concerning giant cell arteritis (Reasonable Hypothesis) (No. 11 of 2021) was introduced to address the issue of determining the circumstances under which veterans, members of Peacekeeping Forces, or members of the Forces might have contracted giant cell arteritis, a systemic autoimmune vasculitis primarily affecting the cranial branches of the carotid arteries, and the subsequent death from this condition. This legislative instrument was made under subsection 196B(2) of the Veterans' Entitlements Act 1986 and applies to claims under section 120A of the Veterans' Entitlements Act 1986 or section 338 of the Military Rehabilitation and Compensation Act 2004. The policy objective of this Statement of Principles is to provide a framework for considering claims related to giant cell arteritis and deaths from giant cell arteritis, ensuring that veterans and other eligible persons can receive appropriate compensation and support. The Repatriation Medical Authority has determined that there is sufficient medical-scientific evidence to establish a connection between the disease and the service of these individuals, thereby facilitating the assessment of their claims.

Scope and Application

The Statement of Principles concerning giant cell arteritis (Reasonable Hypothesis) (No. 11 of 2021) applies to claims under section 120A of the Veterans' Entitlements Act 1986 or section 338 of the Military Rehabilitation and Compensation Act 2004, specifically addressing the conditions of giant cell arteritis and death from giant cell arteritis as they relate to veterans, members of Peacekeeping Forces, or members of the Forces under the Veterans' Entitlements Act 1986, and members under the Military Rehabilitation and Compensation Act 2004. This Statement of Principles is concerned with the establishment of a reasonable hypothesis that links the condition of giant cell arteritis, or death from giant cell arteritis, to the relevant service rendered by the affected individuals. The application of this instrument hinges on the presence of specified factors, such as a history of smoking or difficulties in accessing appropriate clinical management, which must be related to the relevant service and contribute to the material aggravation or contraction of the condition during or before the service. The principles set forth in this document are intended to assist in the assessment of claims related to these conditions, ensuring that the claims are evaluated in light of the sound medical-scientific evidence that supports a connection between the condition and the service in question.

Key Provisions

This Statement of Principles, concerning giant cell arteritis (Reasonable Hypothesis) (No. 11 of 2021), applies to claims under section 120A of the Veterans' Entitlements Act 1986 (VEA) and section 338 of the Military Rehabilitation and Compensation Act 2004 (MRCA). The Statement of Principles addresses the condition of giant cell arteritis, a systemic autoimmune vasculitis affecting large and medium-sized arteries, particularly the cranial branches of the carotid arteries, and death from this condition. It defines giant cell arteritis for the purposes of the Statement, noting that this condition can also be referred to as temporal arteritis or cranial arteritis. The Statement also outlines the factors that must exist to establish a reasonable hypothesis connecting the condition or death from it with the service of veterans, members of Peacekeeping Forces, or members of the Forces under the VEA or members under the MRCA. Specifically, the Statement requires that at least one of the following factors must exist: the individual smoked at least 10 pack-years of tobacco products before the clinical onset or worsening of giant cell arteritis, and if smoking has ceased, the onset or worsening occurred within 20 years of cessation; or the individual was unable to obtain appropriate clinical management for the condition. These factors must be related to the relevant service rendered by the individual. The Statement imposes certain obligations on claimants, requiring them to provide evidence that at least one of the specified factors existed in relation to their service. Additionally, if the factor refers to an injury or disease covered by another Statement of Principles, the terms of that Statement of Principles apply. There are no specific offences, penalties, or consequences for breach outlined in the Statement of Principles itself. However, the underlying Acts, the VEA and the MRCA, provide for various penalties and consequences for false claims, fraud, or other breaches related to veterans' entitlements and military rehabilitation and compensation. These might include fines, imprisonment, or the recovery of payments made under the Acts. The exact penalties and consequences would be determined according to the specific provisions of the VEA or MRCA, as applicable, and any relevant case law.

Legal classification tags

Area of Law
Veterans' Law
Instrument
Legislative Instrument
Concepts
Definitions & Interpretation
Reporting & Disclosure Obligations
Offence Provisions

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.